Relapsed / Refractory Metastatic or Advanced Solid Tumors research hub

An Open-label, Single Agent, Phase I/II Trial Investigating the Safety and Efficacy of RVU120 (SEL120) in Patients with Relapsed / Refractory Metastatic or Advanced Solid Tumors

This study is testing a new medicine called RVU120 for people with advanced cancer that has come back or spread. Doctors want to see if it's safe, what dose works best, and if it helps shrink tumours or slow down the cancer's growth.